http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112791080-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c6ed83b9d5c28c6c356d1d08d58501e7
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-87
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-87
filingDate 2021-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e073193a29a6553091917c62321acc5d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f98f55c36ec57376ead0ddc4bc3322f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b7902ba7f161fbd1e147a41ed6d92b3
publicationDate 2021-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-112791080-A
titleOfInvention Application of resveratrol dimer TVN in the preparation of medicaments for the treatment of osteoarthritis
abstract The invention discloses the application of resveratrol dimer TVN in preparing medicine for treating osteoarthritis. The TVN improves bone loss and protects articular cartilage by inhibiting bone resorption and bone remodeling; and delays the progression of osteoarthritis by improving cartilage degeneration and cartilage damage; at the same time, it inhibits cartilage matrix by maintaining the homeostasis of cartilage matrix. Degradation can be used to develop drugs that can slow or reverse the progression of osteoarthritis.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113967199-A
priorityDate 2021-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109721579-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7083
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281914
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4322
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451374488
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403763
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID487942
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID487942
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID772008
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID3673
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID3673
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID171052
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487318
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID451513
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449012232
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445154
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID17386
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11294
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2723800
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448709835
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID387293

Total number of triples: 42.